Related Experiment Video
Updated: Apr 19, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma
Abdelkader Selmi1, Maud de Saint-Jean1, Anne-Catherine Jallas2
1Université Lyon 1, F-69000 Lyon, France; INSERM UMR-S1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69008 Lyon, France.
Abstract:
In neuroblastoma, MYCN amplification is associated with a worse prognosis and is a criterion used in the clinic to provide intensive treatments to children even with localized disease. In correlation with MYCN amplification, upregulation of TWIST1, a transcription factor playing a crucial role in inhibition of apoptosis and differentiation, was previously reported. Clinical data set analysis of MYCN, MYC and TWIST1 expression permits us to confirm that TWIST1 expression is upregulated in MYCN amplified neuroblastoma but also in a subset of neuroblastoma harboring high expression of MYCN or MYC without gene amplification. In silico analyses reveal the presence of several MYC regulatory motifs (E-Boxes and INR) within the TWIST1 promoter. Using gel shift assay and reporter activity assays, we demonstrate that both N-Myc and c-Myc proteins can bind and activate the TWIST1 promoter. Therefore, we propose TWIST1 as a direct MYC transcriptional target.
Insights
MYCN amplification in neuroblastoma correlates with increased TWIST1 expression. Researchers confirmed TWIST1 is a direct transcriptional target of MYC proteins, impacting cancer progression.
Area of Science:
- Molecular Oncology
- Pediatric Cancer Research
Background:
- MYCN amplification in neuroblastoma signifies a poor prognosis, often necessitating intensive treatment.
- TWIST1, a transcription factor inhibiting apoptosis and differentiation, is upregulated alongside MYCN amplification.
Purpose of the Study:
- To investigate the relationship between MYCN/MYC expression and TWIST1 upregulation in neuroblastoma.
- To determine if MYC proteins directly regulate TWIST1 transcription.
Main Methods:
- Analysis of clinical datasets for MYCN, MYC, and TWIST1 expression.
- In silico promoter analysis to identify MYC regulatory motifs in the TWIST1 gene.
- Gel shift assays and reporter activity assays to assess protein-DNA interactions and transcriptional activation.
Main Results:
- TWIST1 is upregulated in MYCN-amplified neuroblastoma and in neuroblastoma with high MYCN or MYC expression without amplification.
- MYC regulatory motifs (E-Boxes, INR) are present in the TWIST1 promoter.
- N-Myc and c-Myc proteins bind to and activate the TWIST1 promoter.
Conclusions:
- TWIST1 is a direct transcriptional target of MYC proteins in neuroblastoma.
- This finding provides a molecular link between MYC dysregulation and TWIST1 activity in neuroblastoma pathogenesis.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Master Transcription Regulators
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

